Editors Note: We really need to watch this one to see if anything on compounding is included!
Senators Kennedy and Baucus Rush to Keep Health Care in Forefront
These two influential Senators are working behind the scenes on legislation that would dramatically alter the way Americans get health care, hoping their early efforts -- including the release today of a position paper -- will push President-elect Barack Obama to move rapidly on the issue and spare the incoming administration some of the missteps that killed Bill Clinton's health reform initiative in 1994.
Senator Edward M. Kennedy has directed aides over the past several months to convene negotiating sessions with a diverse group of stakeholders, including physicians, patient advocates, small-business owners, and insurers. He intends to have legislation drafted by Inauguration Day.
The first promise Obama made as a presidential candidate was to enact a universal healthcare plan by the end of his first term, but since his victory a week ago, he has focused on repairing the economy and they are concerned that Obama's urgency about taking on health care may wane.
President Clinton came in determined to do something significant on healthcare reform "but did not submit a bill until 10 months after taking office. A president's leadership is more influential and effective before he expends much of his political capital." The Senate maneuvering, combined with an unprecedented level of post-election lobbying by outside interest groups, is intended to hold Obama to his pledge.
"We're doing all we can today to unite Congress around a single, unified bill for early action next year," Kennedy said through an aide.
http://www.washingtonpost.com/wp-dyn/content/article/2008/11/11/AR2008111102511.html
Multi-Dose Vials on the way out?
The FDA has rejected an appeal from New York State's health commissioner to ban the manufacture of multi-dose vials, saying they are an important option for hospitals.
In January, state Health Commissioner Dr. Richard Daines and New York City's health commissioner, Dr. Thomas Frieden, sent FDA Commissioner Dr. Andrew von Eschenbach a letter calling on the FDA to eliminate the manufacture and distribution of multi-dose vials.
The opponents stated in a letter that despite "numerous guidelines and recommendations," some doctors continue to misuse needles and syringes, leading to contamination of multi-dose vials. Daines said he believed it was better to "engineer out" human error by getting rid of multi-dose vials.
But in a letter dated October 20, von Eschenbach said multi-dose vials "are an important dosage option for hospital pharmacies, are less expensive and require less storage space."
Instead, the commissioner said, the FDA was looking at including warning statements on multi-dose vials and posting instructions on the FDA Website on the vials' correct use.
http://www.newsday.com/news/printedition/longisland/ny-liheal185931836nov18,0,7632249.story
New Hampshire Prescription Privacy Law Upheld
The constitutionality of New Hampshire's first-in-the-nation law that restricts drug company access to some information about doctors' prescription-writing habits has been upheld. The ruling by the 1st U.S. Circuit Court of Appeals in Boston overturns a lower court decision that said the confidentiality law unconstitutionally infringed on free speech.
Among other things, drug company sales representatives use the information to target particular doctors and tailor their sales pitches. Patients' names are not included in the data. New Hampshire's law blocks those pitches by restricting access to data that identifies doctors and other prescribers.
http://www.therapeuticsdaily.com/news/article.cfm?contentValue=1866785&contentType=sentryarticle&channelID=33
|